Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Regular Physical Activity Tied to Higher Pain Tolerance

Being physically active over time is associated with higher pain tolerance compared to being consistently sedentary, according to a study published online...

FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information

Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an important priority...

FDA Approves Extended-Release Injection, Brixadi, for Opioid Use Disorder

The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid use disorder. Brixadi...

FDA Approves Posluma (flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

(BUSINESS WIRE) May 30, 2023 --Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET...

FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia

The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired...

First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles

MORRISVILLE, N.C., May 30, 2023. Immorna, a rapidly expanding biotechnology company focusing on the development of multi-platform RNA-based therapeutics...

Research and Pipeline Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial

Study demonstrates statistically significant and clinically relevant reduction in annualized bleeding rate compared to prophylaxis and on-demand intravenous...

Quality, Cost of Care Similar for Allopathic, Osteopathic Hospitalists

The quality and costs of care are similar for allopathic and osteopathic hospitalists caring for Medicare patients, according to a study published online...

619 Million Affected by Low Back Pain Globally in 2020

Overall, 619 million people were affected by low back pain globally in 2020, and the number of prevalent cases is projected to continue increasing, according...

High Dry Night Rate for Users of New Bedwetting AI Alarm

High compliance users of the new bedwetting alarm, GOGOband, which utilizes real-time heart rate variability analysis and applies artificial intelligence...

Upadacitinib Superior to Placebo in Moderate-to-Severe Crohn Disease

For patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published...

Vegan, Vegetarian Diets Linked to Reduction in Cholesterol, Apolipoprotein B

Vegetarian and vegan diets are associated with reduced total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B levels, according to...

Hydrocortisone Does Not Reduce 90-Day Mortality in Septic Shock

For patients with septic shock, intravenous hydrocortisone does not reduce 90-day mortality when compared with placebo, according to a study published...

Main Safety Issues in ED Include Shortage of Personnel in Busy Periods

The main safety issues in the emergency department include shortage of personnel during busy periods, overcrowding due to boarding, and lack of support...

Colchicine Tied to Lower Incidence of TJA in Coronary Artery Disease

For patients with chronic coronary artery disease, colchicine is associated with a reduced incidence of total knee replacement (TKR) and total hip replacement...

Joint Attention-Based AI System Helps Detect Autism

A joint attention-based deep learning system provides good predictive performance for differentiating autism spectrum disorder (ASD) from typical development...

Aquablation Procedure Safe for BPH, With Durable Efficacy

For men with large prostates, the Aquablation procedure is safe, with durable efficacy, according to a study published online April 28 in The Journal of...

Automated Diabetic Macular Ischemia Algorithm Predicts Retinopathy  Progression

For patients with diabetes, an automated binary diabetic macular ischemia (DMI) algorithm using optical coherence tomography angiography (OCTA) images...

Liver Function Tests Can ID Occult Disorders in Systemic Sclerosis

Liver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according...

Vitamin D₃ Supplements Not Tied to Lower Cancer Mortality, Overall

Daily vitamin D₃ supplementation may reduce cancer mortality for some patients, according to a study published in the June issue of Ageing Research Reviews. Sabine...

Read more news...

Recently Added

Recently added consumer and prescribing information: Inpefa, Epkinly, Miebo, Lumryz, Abilify Asimtufii, Veozah, Vowst, RizaFilm, Joenja, Rezzayo

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Posluma Posluma (flotufolastat F 18) a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane...
  • Inpefa Inpefa (sotagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of heart failure.
  • Paxlovid Paxlovid (nirmatrelvir and ritonavir) is a co-packaged product containing nirmatrelvir, a SARS-CoV-2 main protease inhibitor, and...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development